Tumor heterogeneity as a rationale for a multi-epitope approach in an autologous renal cell cancer tumor vaccine

PURPOSE: An autologous tumor vaccine already used successfully in the immune therapy of renal cell carcinoma was investigated in detail. The evaluation of potential tumor markers should allow for the assessment of potency according to pharmaceutical regulations. METHODS: A panel of 36 tumor-associat...

Descripción completa

Detalles Bibliográficos
Autores principales: Wittke, Stefan, Baxmann, Susann, Fahlenkamp, Dirk, Kiessig, Stephan T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4743638/
https://www.ncbi.nlm.nih.gov/pubmed/26889089
http://dx.doi.org/10.2147/OTT.S92182

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4743638/
https://www.ncbi.nlm.nih.gov/pubmed/26889089
http://dx.doi.org/10.2147/OTT.S92182

Ejemplares similares